Percutaneous Transluminal Angioplasty in Patients with Takayasu Arteritis: Five-year Experience

Fava, Mario; Foradori, Giancarlo B.; García, Cristián B.; Cruz, F; Aguilar, Jaime G.; Kramer, Albretch S.; Valdés, Francisco

doi:10.1016/s1051-0443(93)71940-5

Cited by 66 publications

(29 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There are no randomized trials of percutaneous or surgical intervention in this disease (158,(171)(172)(173). Nonrandomized reports have shown that revascularization of either variety may be appropriate, with one caveat.…”

Section: Takayasu Arteritismentioning

confidence: 99%

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

Hiratzka¹,

Bakris²,

Beckman³

et al. 2010

Journal of the American College of Cardiology

1,310

396

View full text Add to dashboard Cite

Section: Takayasu Arteritismentioning

confidence: 99%

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

Hiratzka¹,

Bakris²,

Beckman³

et al. 2010

Journal of the American College of Cardiology

1,310

396

View full text Add to dashboard Cite

“…The 1-year patency of percutaneous interventions with or without stenting was below 60% in most published series. 82,83 However, there has been no systematic study of the effect of the control of inflammation on the patency of vascular interventions.…”

Section: Vascular Interventionsmentioning

confidence: 99%

Giant cell arteritis: a systemic vascular disease

Tatò¹,

Hoffmann²

2008

Vasc Med

View full text Add to dashboard Cite

Giant cell arterits (GCA) is increasingly being recognized as a systemic vascular disease, not confined to the cranial arteries. Epidemiological studies have shown that almost one-third of the patients with GCA develop serious peripheral vascular complications during long-term follow up, and there is growing evidence that unrecognized extracranial involvement may be even more common. GCA of largeand medium-sized peripheral arteries typically leads to long tapering and occlusion of the arterial lumen due to concentric intimal thickening, sometimes accompanied by spontaneous dissection. Depending on the extent of the arterial obliteration and on the anatomy of the involved arterial segment, this may result in severe ischemia of the limbs during the acute phase of the disease. GCA of the aorta usually remains asymptomatic for many years, and leads to a markedly increased risk of aneurysms and dissections, particularly of the thoracic aorta. Evolving vascular imaging techniques such as duplex ultrasound, computer tomography (CT), magnetic resonance imaging (MRI), and fluorine-18-desoxyglucose positron emission tomography (18F-FDG-PET) have greatly improved our ability to detect and study arterial changes in large-artery vasculitis. Boosted by these advances in vascular imaging, vascular specialists are increasingly involved in the early diagnosis, follow-up and treatment of patients with large-vessel vasculitis.

show abstract

“…Balloon angioplasty was considered as a cost-effective, less invasive, and safe method for relieving stenosis. [20] Percutaneous angioplasty yielded excellent results ranging from 81% to 100% and low morbidity and mortality. [21,22] Balloon angioplasty is relatively simple and cost-effective.…”

Section: Discussionmentioning

confidence: 99%

Endovascular Balloon Angioplasty versus Stenting in Patients With Takayasu Arteritis: A Meta-Analysis

Jeong¹,

Jung²,

Song³

et al. 2018

Journal of Vascular Surgery

View full text Add to dashboard Cite

Background: Symptomatic or significant vascular lesions of Takayasu arteritis (TA) need interventions. Although percutaneous transluminal angioplasty with balloon is a less invasive and safe method, stent implantation in TA can be an alternative option. However, superiority between balloon angioplasty and stenting in TA is not conclusive.Methods: A meta-analysis comparing balloon angioplasty and stenting outcomes was performed using the MEDLINE and EMBASE databases.Results: A total of 7 studies on 266 patients and 316 lesions were included. Balloon angioplasty was performed in 186 lesions and stenting in 130 lesions. There were no significant differences in the incidence of both restenosis and other complications between balloon angioplasty and stenting [odds ratio (OR) = 2.39, 95% confidence interval (CI) = 0.66-8.66, P = .18; OR = 1.80, 95% CI = 0.49-6.65, P = .38, respectively]. In the renal arteries, the risk of restenosis in stenting was significantly higher than that in balloon angioplasty (OR = 4.40, 95% CI = 2.14-9.02, P < .001). The clinical efficacy of improving renal hypertension between balloon angioplasty and stenting at the renal artery lesions was similar (OR = 0.65, 95% CI = 0.28-1.51, P = .31); however, acute vascular complications were significantly fewer in stenting than in balloon angioplasty (OR = 0.07, 95% CI = 0.02-0.29, P < .001).Conclusion: This meta-analysis found that balloon angioplasty can yield better results in renal artery interventions than stenting. Nonetheless, it is desirable to avoid vessel dissections during balloon angioplasty, which can eventually require stent implantations.Abbreviations: CI = confidence interval, OR = odds ratio, PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses, TA = Takayasu arteritis.

show abstract

Percutaneous Transluminal Angioplasty in Patients with Takayasu Arteritis: Five-year Experience

Cited by 66 publications

References 7 publications

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease

Giant cell arteritis: a systemic vascular disease

Endovascular Balloon Angioplasty versus Stenting in Patients With Takayasu Arteritis: A Meta-Analysis

Contact Info

Product

Resources

About